These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3673290)

  • 41. [Utilization of released proteins (RPs) of Yersinia enterocolitica for serologic diagnosis of yersiniosis. III. Western-blot].
    Rastawicki W; Jagielski M; Gierczyński R
    Med Dosw Mikrobiol; 2004; 56(4):335-42. PubMed ID: 15959989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reactive arthritis associated bacteria as the etiology of undifferentiated oligoarthritis].
    Sieper J; Braun J; Laitko S; Sörensen H; Wu P; Mielke M; Heesemann J
    Z Rheumatol; 1993; 52(1):19-27. PubMed ID: 7682746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Presence of anti-Yersinia pseudotuberculosis agglutinins during a flare-up of ileal Crohn's disease. Apropos of 3 cases].
    Delchier JC; Constantini D; Soulé JC
    Gastroenterol Clin Biol; 1983; 7(6-7):580-4. PubMed ID: 6873577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of Yersinia enterocolitica isolates and antibody titers. A prospective study in patients with enteritis and healthy controls under bacteriological, serological, epidemiological and clinical aspects.
    Bitzan M; Knapp W; Mauff G; Pulverer G
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Mar; 254(1):78-88. PubMed ID: 6675345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Reactive Yersinia arthritis].
    Vukotić D; Radak-Perović M; Roganović M; Mircetić V
    Srp Arh Celok Lek; 1990; 118(3-4):121-5. PubMed ID: 17977399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The 19 kDa protein of Yersinia enterocolitica O:3 is recognized on the cellular and humoral level by patients with Yersinia induced reactive arthritis.
    Appel H; Mertz A; Distler A; Sieper J; Braun J
    J Rheumatol; 1999 Sep; 26(9):1964-71. PubMed ID: 10493678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Yersinia arthritis. A clinical and serological follow-up examination].
    Anker E; Osnes M
    Tidsskr Nor Laegeforen; 1978 Apr; 98(10):502-5. PubMed ID: 675600
    [No Abstract]   [Full Text] [Related]  

  • 48. [A 2-year evaluation of antibacterial serology adapted to the diagnosis of reactive arthritis (168 cases)].
    Jean-Pierre H; Darbas H; Hérisson C; Momas I; Simon L
    Pathol Biol (Paris); 1989 Jan; 37(1):17-24. PubMed ID: 2648265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Yersiniosis in Poland in 2007].
    Napiórkowska A; Bobel D; Sadkowska-Todys M
    Przegl Epidemiol; 2009; 63(2):221-4. PubMed ID: 19799249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.
    Granfors K; Viljanen M; Tiilikainen A; Toivanen A
    J Infect Dis; 1980 Apr; 141(4):424-9. PubMed ID: 7373079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Yersinia arthritis (review of Finnish experience)].
    Laĭne VA
    Ter Arkh; 1979; 51(7):27-9. PubMed ID: 494080
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acute Yersinia pseudotuberculosis arthritis. 2 new cases].
    Chaouat D; Auquier L; Sacchi A; Caroit M
    Rev Rhum Mal Osteoartic; 1981 Dec; 48(12):827-8. PubMed ID: 7038832
    [No Abstract]   [Full Text] [Related]  

  • 53. [Polyarthritis following Yersinia enterocolitica infection].
    de Leeuw BD; van Dijk R
    Ned Tijdschr Geneeskd; 1977 Apr; 121(15):623-6. PubMed ID: 300852
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of infections with Yersinia pseudotuberculosis and Yersinia enterocolitica in the pathogenesis of chronic inflammatory, rheumatic and collagen diseases.
    Georgescu C; Dan E; Cojocaru M; Plosceanu L
    Med Interne; 1986; 24(3):217-20. PubMed ID: 3534995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of immunodominant CD4+ T cell epitopes in patients with Yersinia-induced reactive arthritis by cytometric cytokine secretion assay.
    Thiel A; Wu P; Lanowska M; Dong J; Radbruch A; Sieper J
    Arthritis Rheum; 2006 Nov; 54(11):3583-90. PubMed ID: 17075864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis.
    Gaston JS; Cox C; Granfors K
    Arthritis Rheum; 1999 Oct; 42(10):2239-42. PubMed ID: 10524699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Yersiniosis in Poland in 2006].
    Bobel D; Sadkowska-Todys M
    Przegl Epidemiol; 2008; 62(2):287-93. PubMed ID: 18807470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies against Yersinia enterocolitica in patients with Reiter's syndrome.
    Kobayashi S; Ogasawara M; Maeda K; Yu DT
    J Lab Clin Med; 1985 Mar; 105(3):380-9. PubMed ID: 3871831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinico-laboratory characteristics of moderately severe forms of Yersinia infection].
    Romanova EI; Tseneva GIa
    Klin Med (Mosk); 1983 Dec; 61(12):113-6. PubMed ID: 6366355
    [No Abstract]   [Full Text] [Related]  

  • 60. [Persistence of IgM-, IgG and IgA-antibodies in Yersinia arthritis].
    Granfors K; Viljanen M; Tiilikainen A; Toivanen A
    Duodecim; 1980; 96(12):850-6. PubMed ID: 7215215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.